---
aliases:
  - Ketamine
has_id_wikidata: Q243547
Commons_category: Ketamine
ATC_code: N01AX03
SPLASH:
  - splash10-000i-0090000000-24585e7c2431b3b9319e
  - splash10-000i-0090000000-85385cf96aa2ac05921a
  - splash10-000i-0090000000-aff2b684d97275321043
  - splash10-000i-0290000000-1707dec51cc3e89964c9
  - splash10-000i-0290000000-c9d734b085ec94dabd9a
  - splash10-004i-0900000000-441a423105753e2c8b9c
  - splash10-004i-0900000000-5b34551c0f97e0bdfb0b
  - splash10-004i-0900000000-6c243d7b1c2e8cf69efa
  - splash10-004i-0900000000-702873d66ce0d419711d
  - splash10-004i-0900000000-8c263bb521fb6ebe6cac
  - splash10-004i-0900000000-95c2a8805f1587266fea
  - splash10-004i-0900000000-ca62e82b4a1dfb81b3b0
  - splash10-004i-0900000000-e23ba411aa96df9b5d6f
  - splash10-004i-0910000000-d00d242dae695dc5aff9
  - splash10-004i-0940000000-054d77385726d4e35e20
  - splash10-004i-0940000000-59871faec16835eb1b3a
  - splash10-004i-1900000000-9e61adc80771178de9d3
  - splash10-00di-0090000000-5f14196db213c95f3e71
  - splash10-00di-0090000000-7704dbbfa717abc4bab2
  - splash10-00di-0190000000-686c139c454aea662d84
  - splash10-00di-0590000000-6d5dead00806bc645985
  - splash10-05br-0390000000-9177663a5915fac51aa7
World_Health_Organisation_international_non_proprietary_name:
  - كيتامين
  - ketamina
  - kétamine
  - ketaminum
  - 氯胺酮
  - ketamine
  - кетамин
Dewey_Decimal_Classification: "615.781"
medical_condition_treated:
  - "[[_Standards/WikiData/WD~pain,81938]]"
  - "[[_Standards/WikiData/WD~substance_abuse,3184856]]"
subject_has_role:
  - "[[_Standards/WikiData/WD~analgesic,173235]]"
  - "[[_Standards/WikiData/WD~dopamine_agonist,600203]]"
  - "[[_Standards/WikiData/WD~Dissociative,900394]]"
  - "[[_Standards/WikiData/WD~excitatory_amino_acid_antagonist,5419644]]"
  - "[[_Standards/WikiData/WD~dissociative_anesthetics,50429828]]"
  - "[[_Standards/WikiData/WD~essential_medicine,35456]]"
different_from:
  - "[[_Standards/WikiData/WD~esketamine,2365493]]"
  - "[[_Standards/WikiData/WD~(RS)_ketamine_hydrochloride,27105184]]"
pregnancy_category:
  - "[[_Standards/WikiData/WD~Australian_pregnancy_category_B3,3679234]]"
  - "[[_Standards/WikiData/WD~US_pregnancy_category_C,28123617]]"
physically_interacts_with:
  - "[[_Standards/WikiData/WD~Glutamate_ionotropic_receptor_NMDA_type_subunit_2A,21115815]]"
  - "[[_Standards/WikiData/WD~Glutamate_ionotropic_receptor_NMDA_type_subunit_2C,21115819]]"
  - "[[_Standards/WikiData/WD~Glutamate_ionotropic_receptor_NMDA_type_subunit_2B,21115816]]"
  - "[[_Standards/WikiData/WD~Glutamate_ionotropic_receptor_NMDA_type_subunit_1,21118862]]"
  - "[[_Standards/WikiData/WD~Glutamate_ionotropic_receptor_NMDA_type_subunit_3A,21118868]]"
  - "[[_Standards/WikiData/WD~Glutamate_ionotropic_receptor_NMDA_type_subunit_2D,21130911]]"
part_of: "[[_Standards/WikiData/WD~response_to_ketamine,21119124]]"
active_ingredient_in:
  - "[[_Standards/WikiData/WD~Ketalar,48825978]]"
  - "[[_Standards/WikiData/WD~Ketathesia,48826009]]"
  - "[[_Standards/WikiData/WD~Ketaset,48826132]]"
  - "[[_Standards/WikiData/WD~Ketaved,48826235]]"
  - "[[_Standards/WikiData/WD~Zetamine,48828311]]"
  - "[[_Standards/WikiData/WD~Ketaject,48828933]]"
  - "[[_Standards/WikiData/WD~Vetaket,48829264]]"
instance_of: "[[_Standards/WikiData/WD~group_of_stereoisomers,59199015]]"
studied_by: "[[_Standards/WikiData/WD~ketamine_in_depression,65939664]]"
subclass_of:
  - "[[_Standards/WikiData/WD~monochlorobenzene,72580449]]"
  - "[[_Standards/WikiData/WD~secondary_amine,73304699]]"
  - "[[_Standards/WikiData/WD~cyclohexanones,76544197]]"
LiverTox_likelihood_score: "[[_Standards/WikiData/WD~LiverTox_toxicity_likelihood_category_B,83284157]]"
has_use:
  - "[[_Standards/WikiData/WD~Ketamine_assisted_psychotherapy,113144093]]"
  - "[[_Standards/WikiData/WD~medication,12140]]"
by_product: "[[_Standards/WikiData/WD~CanKet,114763654]]"
mass: 237.092042
PubChem_CID: "3821"
RxNorm_CUI: "6130"
NSC_number: "70151"
UNII: 690G0D6V8H
InChIKey: YQEZLKZALYSWHR-UHFFFAOYSA-N
Reaxys_registry_number: "2216965"
InChI: InChI=1S/C13H16ClNO/c1-15-13(9-5-4-8-12(13)16)10-6-2-3-7-11(10)14/h2-3,6-7,15H,4-5,8-9H2,1H3
chemical_formula: C₁₃H₁₆ClNO
canonical_SMILES: CNC1(CCCCC1=O)C2=CC=CC=C2Cl
chemical_structure: http://commons.wikimedia.org/wiki/Special:FilePath/%28%C2%B1%29-Ketamine%20Structural%20Formula%20V1.svg
EC_number: 229-804-1
CAS_Registry_Number: 6740-88-1
UMLS_CUI: C0022614
MeSH_tree_code: D02.455.426.392.368.367.652
DSSTOX_compound_identifier: DTXCID703187
---

# [[Ketamine]] 

#is_/same_as :: [[WD~(RS)_ketamine,243547]] 

## #has_/text_of_/abstract 

> **Ketamine** is a cyclohexanone-derived general anesthetic and NMDA receptor antagonist 
> with analgesic and hallucinogenic properties, 
> used medically for anesthesia, depression, and pain management. 
> 
> Ketamine exists as its two enantiomers, S- (esketamine) and R- (arketamine), 
> and has antidepressant action likely involving other mechanisms in addition to NMDA antagonism.
>
> At anesthetic doses, ketamine induces a state of dissociative anesthesia, 
> a trance-like state providing pain relief, sedation, and amnesia. 
> 
> Its distinguishing features as an anesthestic are preserved breathing and airway reflexes, 
> stimulated heart function with increased blood pressure, and moderate bronchodilation.  
> As an anesthetic, it is used especially in trauma, emergency, and pediatric cases. 
> At lower, sub-anesthetic doses, it is used as a treatment for pain and treatment-resistant depression. 
>
> Ketamine is legally used in medicine but is also tightly controlled, 
> as it is used as a recreational drug for its hallucinogenic and dissociative effects. 
> When used recreationally, it is found both in crystalline powder and liquid form, 
> and is often referred to by users as "Ket", "Special K" or simply "K". 
> 
> The long-term effects of repeated use are largely unknown and are an area of active investigation. 
> Liver and urinary toxicity have been reported 
> among regular users of high doses of ketamine for recreational purposes.  
> Ketamine can cause dissociation and nausea, and other adverse effects, 
> and is contraindicated in severe heart or liver disease, and uncontrolled psychosis. 
> Ketamine’s clinical and antidepressant effects can be influenced by co-administration of other drugs, though these interactions are variable and not yet fully understood.
>
> Ketamine was first synthesized in 1962; it was derived from phencyclidine in pursuit of a safer anesthetic with fewer hallucinogenic effects. It was approved for use in the United States in 1970. It has been regularly used in veterinary medicine and was extensively used for surgical anesthesia in the Vietnam War.  It later gained prominence for its rapid antidepressant effects discovered in 2000, marking a major breakthrough in depression treatment. Racemic ketamine, especially at higher doses, may be more effective and longer-lasting than esketamine in reducing depression severity. It is on the World Health Organization's List of Essential Medicines. It is available as a generic medication.
>
> [Wikipedia](https://en.wikipedia.org/wiki/Ketamine) 


